Literature DB >> 22850876

Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.

Amandine Crequer1, Anja Troeger, Etienne Patin, Cindy S Ma, Capucine Picard, Vincent Pedergnana, Claire Fieschi, Annick Lim, Avinash Abhyankar, Laure Gineau, Ingrid Mueller-Fleckenstein, Monika Schmidt, Alain Taieb, James Krueger, Laurent Abel, Stuart G Tangye, Gérard Orth, David A Williams, Jean-Laurent Casanova, Emmanuelle Jouanguy.   

Abstract

Epidermodysplasia verruciformis (EV) is a rare genetic disorder characterized by increased susceptibility to specific human papillomaviruses, the betapapillomaviruses. These EV-HPVs cause warts and increase the risk of skin carcinomas in otherwise healthy individuals. Inactivating mutations in epidermodysplasia verruciformis 1 (EVER1) or EVER2 have been identified in most, but not all, patients with autosomal recessive EV. We found that 2 young adult siblings presenting with T cell deficiency and various infectious diseases, including persistent EV-HPV infections, were homozygous for a mutation creating a stop codon in the ras homolog gene family member H (RHOH) gene. RHOH encodes an atypical Rho GTPase expressed predominantly in hematopoietic cells. Patients' circulating T cells contained predominantly effector memory T cells, which displayed impaired TCR signaling. Additionally, very few circulating T cells expressed the β7 integrin subunit, which homes T cells to specific tissues. Similarly, Rhoh-null mice exhibited a severe overall T cell defect and abnormally small numbers of circulating β7-positive cells. Expression of the WT, but not of the mutated RHOH, allele in Rhoh-/- hematopoietic stem cells corrected the T cell lymphopenia in mice after bone marrow transplantation. We conclude that RHOH deficiency leads to T cell defects and persistent EV-HPV infections, suggesting that T cells play a role in the pathogenesis of chronic EV-HPV infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850876      PMCID: PMC3428089          DOI: 10.1172/JCI62949

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

Review 1.  Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?

Authors:  Alexandre Alcaïs; Lluis Quintana-Murci; David S Thaler; Erwin Schurr; Laurent Abel; Jean-Laurent Casanova
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

2.  RhoH is important for positive thymocyte selection and T-cell receptor signaling.

Authors:  Tatjana Dorn; Ursula Kuhn; Gerd Bungartz; Sebastian Stiller; Martina Bauer; Joachim Ellwart; Thorsten Peters; Karin Scharffetter-Kochanek; Monika Semmrich; Melanie Laschinger; Bernhard Holzmann; Wolfgang E F Klinkert; Per Thor Straten; Tania Køllgaard; Michael Sixt; Cord Brakebusch
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

3.  Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis.

Authors:  J S Schechner; R L Edelson; J M McNiff; P W Heald; J S Pober
Journal:  Lab Invest       Date:  1999-05       Impact factor: 5.662

4.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25.

Authors:  N Ramoz; A Taïeb; L A Rueda; L S Montoya; B Bouadjar; M Favre; G Orth
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

5.  Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.

Authors:  Gianluca Gaidano; Laura Pasqualucci; Daniela Capello; Eva Berra; Clara Deambrogi; Davide Rossi; Luigi Maria Larocca; Annunziata Gloghini; Antonino Carbone; Riccardo Dalla-Favera
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

6.  RhoH regulates subcellular localization of ZAP-70 and Lck in T cell receptor signaling.

Authors:  Hee-Don Chae; Jamie E Siefring; David A Hildeman; Yi Gu; David A Williams
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

7.  Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Authors:  Cindy Berthelot; Mary C Dickerson; Peter Rady; Qin He; Farhad Niroomand; Stephen K Tyring; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

8.  Regulation of T cell receptor signaling by activation-induced zinc influx.

Authors:  Mingcan Yu; Won-Woo Lee; Deepak Tomar; Sergey Pryshchep; Marta Czesnikiewicz-Guzik; David L Lamar; Guangjin Li; Karnail Singh; Lu Tian; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Exp Med       Date:  2011-03-21       Impact factor: 14.307

9.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

10.  TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins.

Authors:  Gabor Keresztes; Hideki Mutai; Stefan Heller
Journal:  BMC Genomics       Date:  2003-06-17       Impact factor: 3.969

View more
  44 in total

1.  Efficient generation of human natural killer cell lines by viral transformation.

Authors:  B Vogel; K Tennert; F Full; A Ensser
Journal:  Leukemia       Date:  2013-06-21       Impact factor: 11.528

Review 2.  Chemokines, their receptors and human disease: the good, the bad and the itchy.

Authors:  Vanessa L Bryant; Charlotte A Slade
Journal:  Immunol Cell Biol       Date:  2015-04       Impact factor: 5.126

Review 3.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

4.  RhoH participates in a multi-protein complex with the zinc finger protein kaiso that regulates both cytoskeletal structures and chemokine-induced T cells.

Authors:  Akihisa Mino; Anja Troeger; Christian Brendel; Alan Cantor; Chad Harris; Marioara F Ciuculescu; David A Williams
Journal:  Small GTPases       Date:  2016-08-31

5.  RhoH is a negative regulator of eosinophilopoiesis.

Authors:  Christina Stoeckle; Barbara Geering; Shida Yousefi; Saša Rožman; Nicola Andina; Charaf Benarafa; Hans-Uwe Simon
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

Review 6.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 7.  Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders.

Authors:  Anja Troeger; David A Williams
Journal:  Exp Cell Res       Date:  2013-07-11       Impact factor: 3.905

8.  Loss of ARHGEF1 causes a human primary antibody deficiency.

Authors:  Amine Bouafia; Sébastien Lofek; Julie Bruneau; Loïc Chentout; Hicham Lamrini; Amélie Trinquand; Marie-Céline Deau; Lucie Heurtier; Véronique Meignin; Capucine Picard; Elizabeth Macintyre; Olivier Alibeu; Marc Bras; Thierry Jo Molina; Marina Cavazzana; Isabelle André-Schmutz; Anne Durandy; Alain Fischer; Eric Oksenhendler; Sven Kracker
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

9.  EVER2 deficiency is associated with mild T-cell abnormalities.

Authors:  Amandine Crequer; Capucine Picard; Vincent Pedergnana; Annick Lim; Shen-Ying Zhang; Laurent Abel; Slawomir Majewski; Jean-Laurent Casanova; Stefania Jablonska; Gerard Orth; Emmanuelle Jouanguy
Journal:  J Clin Immunol       Date:  2012-08-19       Impact factor: 8.317

10.  Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components.

Authors:  Chuan-Jin Wu; Xing Li; Connie L Sommers; Kiyoto Kurima; Sunmee Huh; Grace Bugos; Lijin Dong; Wenmei Li; Andrew J Griffith; Lawrence E Samelson
Journal:  J Biol Chem       Date:  2020-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.